Evidence map›Paper›PMID 37000340›Full record

ReviewCurrent oncology reports2023

Recent Advances in Melanoma Diagnosis and Prognosis Using Machine Learning Methods.

Sarah Grossarth, Dominique Mosley, Christopher Madden, Jacqueline Ike, Isabelle Smith, Yuankai Huo, Lee Wheless

Abstract readReview
In one paragraph

Review in Current oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah GrossarthQuillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Dominique MosleyVanderbilt University School of Medicine, Nashville, TN, USA.
Christopher MaddenDepartment of Dermatology, Vanderbilt University Medicine Center, Nashville, TN, USA.
Jacqueline IkeDepartment of Dermatology, Vanderbilt University Medicine Center, Nashville, TN, USA.
Isabelle SmithDepartment of Dermatology, Vanderbilt University Medicine Center, Nashville, TN, USA.
Yuankai HuoDepartment of Computer Science and Electrical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Lee WhelessDepartment of Dermatology, Vanderbilt University Medicine Center, Nashville, TN, USA. lee.e.wheless@vumc.org.ORCID http://orcid.org/0000-0002-8162-5971

Funding

Identifying clinical and genetic factors for risk of multiple skin cancers in organ transplant recipientsIK2CX002452 · VA · VETERANS HEALTH ADMINISTRATION · PI LEE E WHELESS · 2023 to 2026
–
CSRD VA IK2 CX002452
6 · The paper itself

Abstract

purpose of reviewThe purpose was to summarize the current role and state of artificial intelligence and machine learning in the diagnosis and management of melanoma. RECENT

findingsDeep learning algorithms can identify melanoma from clinical, dermoscopic, and whole slide pathology images with increasing accuracy. Efforts to provide more granular annotation to datasets and to identify new predictors are ongoing. There have been many incremental advances in both melanoma diagnostics and prognostic tools using artificial intelligence and machine learning. Higher quality input data will further improve these models' capabilities.

Indexed as

MelanomaSkin NeoplasmsArtificial IntelligenceDermoscopyHumansMachine LearningPrognosisArtificial intelligenceDeep learningDermoscopyDigital pathologyMachine LearningMelanoma

Identifiers

PMID37000340
PMCPMC10339689

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.